Solid Biosciences Inc.

Advancing gene therapies and technologies for rare neuromuscular and cardiac diseases.

SLDB | US

Overview

Corporate Details

ISIN(s):: US83422E2046
LEI:
Country:: United States of America
Address:: 500 RUTHERFORD AVENUE, 2129 CHARLESTOWN
Website:: https://www.solidbio.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Solid Biosciences is a precision genetic medicine company dedicated to advancing a diverse portfolio of gene therapy candidates. The company focuses on treating rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich’s ataxia, catecholaminergic polymorphic ventricular tachycardia (CPVT), and various cardiomyopathies. In addition to its therapeutic pipeline, Solid Biosciences develops innovative enabling technologies, such as libraries of genetic regulators, to improve gene therapy delivery across the industry. Founded by individuals directly impacted by Duchenne, the company maintains a patient-focused mission to improve the lives of people living with devastating rare genetic diseases through scientific and technological expertise.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Solid Biosciences Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Solid Biosciences Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Solid Biosciences Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ECO ANIMAL HEALTH GROUP PLC Develops pharmaceuticals for respiratory & enteric diseases in global swine and poultry markets.	United Kingdom	EAH
Ectin Research AB Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.	Sweden	ECTIN B
Edesa Biotech, Inc. Develops treatments for inflammatory and immune diseases like Acute Respiratory Distress Syndrome.	United States of America	EDSA
Edgewise Therapeutics, Inc. Developing novel therapeutics for rare and serious muscle disorders.	United States of America	EWTX
Editas Medicine, Inc. Developing CRISPR-based genomic medicines to treat serious and rare genetic diseases.	United States of America	EDIT
Eevia Health Plc Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.	Finland	EEVIA
Egetis Therapeutics Develops and commercializes drugs for serious rare diseases with unmet medical needs.	Sweden	EGTX
EIKEN CHEMICAL CO.,LTD. Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.	Japan	4549
Eisai Co., Ltd. A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.	Japan	4523
Elanco Animal Health Inc Develops medicines, vaccines, and services to treat and prevent disease in pets and farm animals.	United States of America	ELAN